Latest Asx News

Enlitic, Inc. has launched a A$10 million placement alongside an offer of 125 million unquoted options, aiming to fuel growth in its AI-driven healthcare technology business. The move underscores both funding ambitions and the complex risks tied to AI adoption and market dynamics.

Ventia Services Group has locked in a $100 million, five-year contract with Tuatahi First Fibre, reinforcing its role as a key player in New Zealand's fibre infrastructure landscape.

Silk Logistics has announced a postponement of its shareholder Scheme Meeting due to an extended review by the Australian Competition and Consumer Commission (ACCC) of DP World Australia’s proposed acquisition.

EQ Resources reports promising preliminary tungsten recovery results from Wolfram Camp stockpiles, achieving an 86% recovery rate and validating advanced X-ray sorting technology. This breakthrough supports the company’s vision for a low-impact regional tungsten hub in Queensland.

Cobre Limited has announced a fully underwritten loyalty options offer to raise approximately $1.18 million, offering eligible shareholders one new option for every three shares held at $0.008 each. The new options carry an exercise price of $0.066 and expire in November 2028.

Cobre Limited has secured $500,000 through a placement and is now launching a fully underwritten Loyalty Options Rights Issue to raise approximately AU$1.18 million, supporting its capital-light, catalyst-rich copper exploration strategy in Botswana.

EQ Resources reports promising preliminary results from tungsten stockpile testing at Wolfram Camp, achieving an 86% recovery rate using advanced X-ray sorting technology. The company is advancing plans for a regional tungsten hub to enhance operational efficiency and sustainability.

WCM Global Growth Limited has renewed its on-market share buy-back program for 12 months, signaling ongoing confidence in its capital management strategy amid evolving market conditions.

NH3 Clean Energy reports strong Pre-FEED results for its WAH2 clean ammonia project, highlighting robust economics and strategic partnerships while facing key risks around gas supply and funding.

Clarity Pharmaceuticals’ novel PET imaging agent Cu-SAR-Bombesin demonstrated safety and effectiveness in detecting prostate cancer recurrence missed by standard scans in its Phase II SABRE trial. The agent identified lesions in about one-third of patients with negative or equivocal standard imaging.

Invion Limited launches a Loyalty Option entitlement offer aimed at raising up to $16 million to support its advancing cancer clinical trials, including a promising anogenital cancer study with Peter MacCallum Cancer Centre.

New World Resources has successfully completed a placement of 32 million shares at $0.02 each to its board and senior management, following shareholder approval. This move subtly reshapes the company’s capital structure ahead of its copper and base metals projects in the US.